# Sanofi (Turkey)

> organization

**Wikidata**: [Q100956149](https://www.wikidata.org/wiki/Q100956149)  
**Source**: https://4ort.xyz/entity/sanofi-turkey

## Summary
Sanofi (Turkey) is a pharmaceutical subsidiary of the global healthcare company Sanofi, established in 1973 and headquartered in Istanbul. It operates as a key player in Turkey's healthcare sector, focusing on pharmaceuticals, vaccines, and medical solutions. As part of the Sanofi Group, it integrates international expertise with local healthcare needs.

## Key Facts
- **Inception**: 1973
- **Headquarters**: Istanbul, Turkey (coordinates: 40.891241° N, 29.392432° E)
- **Parent Organization**: Sanofi (global multinational pharmaceutical company)
- **ROR ID**: 040k92z84
- **GRID ID**: grid.508760.c
- **Scilit Organization ID**: 98362
- **Website**: https://www.sanofi.com.tr/
- **Country**: Turkey (transcontinental country in Asia and Europe)
- **Aliases**: Sanofi-Synthélabo
- **Classification**: Business (commercial/industrial organization)

## FAQs
**What is Sanofi (Turkey)'s relationship to the global Sanofi Group?**  
Sanofi (Turkey) is a subsidiary of the multinational pharmaceutical company Sanofi, operating under its global network to provide healthcare solutions tailored to the Turkish market.

**When and where was Sanofi (Turkey) established?**  
The company was founded in 1973, with its headquarters located in Istanbul, Turkey, at coordinates 40.891241° N, 29.392432° E.

**What are Sanofi (Turkey)'s primary focus areas?**  
The entity specializes in pharmaceuticals, vaccines, and medical products, addressing healthcare needs in Turkey while aligning with Sanofi's global research and development initiatives.

**How does Sanofi (Turkey) contribute to the Turkish economy?**  
As a business entity in Turkey, it participates in the country's healthcare and pharmaceutical sectors, contributing to economic activity through employment, innovation, and the provision of medical products.

## Why It Matters
Sanofi (Turkey) plays a critical role in bridging international pharmaceutical advancements with local healthcare demands in Turkey. As a long-standing subsidiary of a global healthcare leader, it enhances access to medicines, vaccines, and therapeutic solutions, directly impacting public health outcomes. Its operations reflect Turkey's integration into the global healthcare industry, fostering medical innovation and economic growth within the region.

## Notable For
- **Long-Standing Presence**: Established in 1973, marking decades of operation in Turkey's pharmaceutical sector.
- **Specialized Focus**: Concentrates on high-impact areas such as diabetes, oncology, and vaccines, aligning with global health priorities.
- **Integration with Global Networks**: Benefits from Sanofi's worldwide R&D capabilities while addressing Turkey-specific healthcare challenges.
- **Strategic Location**: Headquartered in Istanbul, a major economic and cultural hub connecting Europe and Asia.

## Body

### History and Corporate Structure
Sanofi (Turkey) was founded in 1973 as part of Sanofi's global expansion strategy. As a subsidiary, it operates under the parent company's governance while maintaining localized operations in Turkey. The entity is classified as a business and functions as an organization undertaking commercial activities in the pharmaceutical and healthcare sectors.

### Headquarters and Operations
The company's headquarters are in Istanbul, Turkey's largest city and economic center, at coordinates 40.891241° N, 29.392432° E. This strategic location facilitates access to regional markets and regulatory frameworks. Sanofi (Turkey) focuses on pharmaceutical production, medical research, and the distribution of vaccines and diagnostic tools, contributing to Turkey's healthcare infrastructure.

### Digital Presence and Identifiers
Sanofi (Turkey) maintains an official website (https://www.sanofi.com.tr/) for public and professional engagement. The entity is cataloged in international research databases, including a Scilit Organization ID (98362), GRID ID (grid.508760.c), and ROR ID (040k92z84), ensuring visibility in academic and industry networks.

### Related Entities and Global Context
As a subsidiary of **Sanofi**, the Turkish entity aligns with the parent company's mission to develop and distribute medical solutions globally. Its operations are influenced by Turkey's economic and healthcare policies, including its membership in international organizations like the UN and NATO. Sanofi (Turkey) also interacts with local regulatory bodies to comply with pharmaceutical standards and address public health needs.

### Technical Specifications
- **Inception Year**: 1973
- **Geographic Coordinates**: 40.891241° N, 29.392432° E (Istanbul headquarters)
- **Organizational Aliases**: Sanofi-Synthélabo
- **Classifications**: Business, pharmaceutical company, medical research organization

### Role in Turkish Healthcare
Sanofi (Turkey) contributes to Turkey's healthcare ecosystem by providing access to innovative medicines and vaccines. Its work in areas like diabetes management and infectious disease prevention aligns with national health priorities, supporting Turkey's efforts to improve life expectancy and quality of life. The company's presence also fosters collaboration between Turkish medical professionals and global research networks.

### Challenges and Compliance
Operating in Turkey's regulatory environment, Sanofi (Turkey) navigates policies related to pharmaceutical approvals, intellectual property, and healthcare accessibility. The company must adapt to economic fluctuations, such as currency changes (Turkish lira) and trade dynamics influenced by Turkey's transcontinental position and international relations.

### Global Influence and Local Impact
Through its affiliation with Sanofi, the Turkish subsidiary benefits from multinational resources while tailoring solutions to local demographics and health challenges. This dual focus enables Sanofi (Turkey) to address both universal healthcare needs and region-specific issues, such as prevalent diseases or demographic health trends in Turkey.

## References

1. GRID release 2020-10-06
2. ROR Data Dump 6.0 (October 2020)